Lysosomal trafficking of TGFBIp via Caveolae-mediated endocytosis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Choi, Seung Il ^a   Maeng, Yong Sun ^a   Kim, Tae Im ^a   Lee, Yangsin ^b   Kim, Yong Sun ^c   Kim, Eung Kweon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BAFILOMYCIN A1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; PROTEASOME; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA INDUCED PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; BETAIG-H3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CAVEOLA; CELL LYSATE; CONTROLLED STUDY; CORNEA DYSTROPHY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; FIBROBLAST; GOLGI COMPLEX; GRANULAR CORNEAL DYSTROPHY TYPE 2; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; INTERNALIZATION; LYSOSOME; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TRAFFICKING; PROTEIN TRANSPORT; TRANSMISSION ELECTRON MICROSCOPY; ADOLESCENT; ADULT; CHEMISTRY; CHILD; CORNEA DISEASE; CYTOLOGY; FEMALE; MALE; METABOLISM; PATHOLOGY; PROTEIN MOTIF; YOUNG ADULT;

ADOLESCENT; ADULT; AMINO ACID MOTIFS; CAVEOLAE; CHILD; CORNEAL DISEASES; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; GOLGI APPARATUS; HUMANS; INTEGRIN ALPHAVBETA3; LYSOSOMES; MALE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN; YOUNG ADULT;

EID: 84929492259     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119561     Document Type: Article

References (89)

1. Munier FL, Korvatska E, Djemai A, Le Paslier D, Zografos L, Pescia G, et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet. 1997; 15: 247-251. PMID: 9054935
2. Klintworth GK. Advances in the molecular genetics of corneal dystrophies. Am J Ophthalmol. 1999; 128: 747-754. PMID: 10612512
3. Munier FL, Frueh BE, Othenin-Girard P, Uffer S, Cousin P, Wang MX, et al. BIGH3 mutation spectrum in corneal dystrophies. Invest Ophthalmol Vis Sci. 2002; 43: 949-954. PMID: 11923233
4. Yuan C, Yang MC, Zins EJ, Boehlke CS, Huang AJ. Identification of the promoter region of the human betaIGH3 gene. Mol Vis. 2004; 10: 351-360. PMID: 15162097
5. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 1999; 99: 81-92. PMID: 10520996
6. Runager K, Enghild JJ, Klintworth GK. Focus on molecules: Transforming growth factor beta induced protein (TGFBIp). Exp Eye Res. 2008; 87: 298-299. doi: 10.1016/j.exer.2007.12.001 PMID: 18291366
7. Skonier J, Bennett K, Rothwell V, Kosowski S, Plowman G, Wallace P, et al. beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol. 1994; 13: 571-584. PMID: 8024701
8. Dieudonne SC, Kerr JM, Xu T, Sommer B, DeRubeis AR, Kuznetsov SA, et al. Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone. J Cell Biochem. 1999; 76: 231-243. PMID: 10618640
9. Kim JE, Kim EH, Han EH, Park RW, Park IH, Jun SH, et al. A TGF-beta-inducible cell adhesion molecule, betaig-h3, is downregulated in melorheostosis and involved in osteogenesis. J Cell Biochem. 2000; 77: 169-178. PMID: 10723084
10. Rawe IM, Zhan Q, Burrows R, Bennett K, Cintron C. Beta-ig. Molecular cloning and in situ hybridization in corneal tissues. Invest Ophthalmol Vis Sci. 1997; 38: 893-900. PMID: 9112985
11. Park SW, Bae JS, Kim KS, Park SH, Lee BH, Choi JY, et al. Beta ig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with alpha3beta1 integrin. Exp Mol Med. 2004; 36: 211-219. PMID: 15272232
12. Zamilpa R, Rupaimoole R, Phelix CF, Somaraki-Cormier M, Haskins W, Asmis R, et al. C-terminal fragment of transforming growth factor beta-induced protein (TGFBIp) is required for apoptosis in human osteosarcoma cells. Matrix Biol. 2009; 28: 347-353. doi: 10.1016/j.matbio.2009.05.004 PMID: 19505574
13. Ahmed AA, Mills AD, Ibrahim AE, Temple J, Blenkiron C, Vias M, et al. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell. 2007; 12: 514-527. PMID: 18068629
14. LeBaron RG, Bezverkov KI, Zimber MP, Pavelec R, Skonier J, Purchio AF. Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol. 1995; 104: 844-849. PMID: 7738366
15. Billings PC, Herrick DJ, Kucich U, Engelsberg BN, Abrams WR, Macarak EJ, et al. Extracellular matrix and nuclear localization of beta ig-h3 in human bladder smooth muscle and fibroblast cells. J Cell Biochem. 2000; 79: 261-273. PMID: 10967553
16. Kim JE, Jeong HW, Nam JO, Lee BH, Choi JY, Park RW, et al. Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J Biol Chem. 2002; 277: 46159-46165. PMID: 12270930
17. Cheng Z. Protein translocation through the Sec61/SecY channel. Biosci Rep. 2010; 30: 201-207. doi: 10.1042/BSR20090158 PMID: 20156192
18. Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol. 2009; 10: 148-155. doi: 10.1038/nrm2617 PMID: 19122676
19. Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J. 2011; 30: 4701-4711. doi: 10.1038/ emboj.2011.398 PMID: 22068051
20. Mayor S, Pagano RE. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol. 2007; 8: 603-612. PMID: 17609668
21. Ivanov AI. Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol. 2008; 440: 15-33. doi: 10.1007/978-1-59745-178-9-2 PMID: 18369934
22. Van Amersfoort ES, Van Strijp JA. Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry. 1994; 17: 294-301. PMID: 7875036
23. Marchina E, Barlati S. Degradation of human plasma and extracellular matrix fibronectin by tissue type plasminogen activator and urokinase. Int J Biochem Cell Biol. 1996; 28: 1141-1150. PMID: 8930138
24. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol. 1998; 10: 602-608. PMID: 9818170
25. Godyna S, Liau G, Popa I, Stefansson S, Argraves WS. Identification of the low density lipoprotein receptor- related protein (LRP) as an endocytic receptor for thrombospondin-1. J Cell Biol. 1995; 129: 1403-1410. PMID: 7775583
26. Memmo LM, McKeown-Longo P. The alphavbeta5 integrin functions as an endocytic receptor for vitronectin. J Cell Sci. 1998; 111 (Pt 4): 425-433.
27. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell. 2003; 114: 33-45. PMID: 12859896
28. Kurban G, Hudon V, Duplan E, Ohh M, Pause A. Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis. Cancer Res. 2006; 66: 1313-1319. PMID: 16452184
29. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature. 2001; 411: 375-379. PMID: 11357145
30. Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ. Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol. 1997; 29: 5-17. PMID: 9076937
31. Poole AR, Nelson F, Dahlberg L, Tchetina E, Kobayashi M, Yasuda T, et al. Proteolysis of the collagen fibril in osteoarthritis. Biochem Soc Symp. 2003: 115-123.
32. Kim BY, Olzmann JA, Choi SI, Ahn SY, Kim TI, Cho HS, et al. Corneal dystrophy-associated R124H mutation disrupts TGFBI interaction with Periostin and causes mislocalization to the lysosome. J Biol Chem. 2009; 284: 19580-19591. doi: 10.1074/jbc.M109.013607 PMID: 19478074
33. Choi SI, Kim BY, Dadakhujaev S, Oh JY, Kim TI, Kim JY, et al. Impaired autophagy and delayed autophagic clearance of transforming growth factor beta-induced protein (TGFBI) in granular corneal dystrophy type 2. Autophagy. 2012; 8: 1782-1797. doi: 10.4161/auto.22067 PMID: 22995918
34. Choi SI, Kim TI, Kim KS, Kim BY, Ahn SY, Cho HJ, et al. Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II. Am J Pathol. 2009; 175: 248-261. doi: 10.2353/ajpath.2009.081001 PMID: 19497990
35. Jester JV, Huang J, Fisher S, Spiekerman J, Chang JH, Wright WE, et al. Myofibroblast differentiation of normal human keratocytes and hTERT, extended-life human corneal fibroblasts. Invest Ophthalmol Vis Sci. 2003; 44: 1850-1858. PMID: 12714615
36. Choi SI, Kim KS, Oh JY, Jin JY, Lee GH, Kim EK. Melatonin induces autophagy via an mTOR-dependent pathway and enhances clearance of mutant-TGFBIp. J Pineal Res. 2013; 54: 361-372. doi: 10. 1111/jpi.12039 PMID: 23363291
37. Kim TI, Kim H, Lee DJ, Choi SI, Kang SW, Kim EK. Altered mitochondrial function in type 2 granular corneal dystrophy. Am J Pathol. 2011; 179: 684-692. doi: 10.1016/j.ajpath.2011.04.005 PMID: 21699880
38. Peters PJ, Bos E, Alexander G. Cryo-Immunogold Electron Microscopy. Curr Protoc Cell Biol. 2006; Chapter 4: Unit 4.7.
39. Lippincott-Schwartz J, Yuan LC, Bonifacino JS, Klausner RD. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell. 1989; 56: 801-813. PMID: 2647301
40. Griffiths G, Quinn P, Warren G. Dissection of the Golgi complex. I. Monensin inhibits the transport of viral membrane proteins from medial to trans Golgi cisternae in baby hamster kidney cells infected with Semliki Forest virus. J Cell Biol. 1983; 96: 835-850. PMID: 6682112
41. Tartakoff AM. Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell. 1983; 32: 1026-1028. PMID: 6340834
42. Kim BH, Kim JI, Choi EK, Carp RI, Kim YS. A neuronal cell line that does not express either prion or doppel proteins. Neuroreport. 2005; 16: 425-429. PMID: 15770145
43. Pelkmans L, Puntener D, Helenius A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science. 2002; 296: 535-539. PMID: 11964480
44. Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem. 1997; 272: 25968-25975. PMID: 9325331
45. Le PU, Nabi IR. Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J Cell Sci. 2003; 116: 1059-1071. PMID: 12584249
46. Parton RG, Richards AA. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic. 2003; 4: 724-738. PMID: 14617356
47. Zhang AY, Yi F, Zhang G, Gulbins E, Li PL. Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension. 2006; 47: 74-80. PMID: 16344372
48. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol. 2003; 5: 410-421. PMID: 12717440
49. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000; 1: 31-39. PMID: 11413487
50. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct. 1998; 23: 33-42. PMID: 9639028
51. Fra AM, Williamson E, Simons K, Parton RG. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci U S A. 1995; 92: 8655-8659. PMID: 7567992
52. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 2001; 293: 2449-2452. PMID: 11498544
53. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, et al. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem. 1997; 272: 29337-29346. PMID: 9361015
54. Bretscher MS. Circulating integrins: alpha 5 beta 1, alpha 6 beta 4 and Mac-1, but not alpha 3 beta 1, alpha 4 beta 1 or LFA-1. EMBO J. 1992; 11: 405-410. PMID: 1531629
55. Pellinen T, Ivaska J. Integrin traffic. J Cell Sci. 2006; 119: 3723-3731. PMID: 16959902
56. Son HN, Nam JO, Kim S, Kim IS. Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind alphavbeta3 integrin, leading to anti-angiogenic and anti-tumor effects. Biochim Biophys Acta. 2013; 1833: 2378-2388. doi: 10.1016/j.bbamcr.2013.06.012 PMID: 23792174
57. Tumbarello DA, Temple J, Brenton JD. ss3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells. Mol Cancer. 2012; 11: 36. doi: 10. 1186/1476-4598-11-36 PMID: 22640878
58. Hicke L, Riezman H. Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis. Cell. 1996; 84: 277-287. PMID: 8565073
59. Choi SI, Kim BY, Dadakhujaev S, Jester JV, Ryu H, Kim TI, et al. Inhibition of TGFBIp expression by lithium: implications for TGFBI-linked corneal dystrophy therapy. Invest Ophthalmol Vis Sci. 2011; 52: 3293-3300. doi: 10.1167/iovs.10-6405 PMID: 21310903
60. Bae JS, Lee SH, Kim JE, Choi JY, Park RW, Park JY, et al. beta ig-h3 supports keratinocyte adhesion, migration, and proliferation through alpha 3 beta 1 integrin. Biochem Biophy Res Comm. 2002; 294: 940-948. PMID: 12074567
61. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 1992; 11: 511-522. PMID: 1388724
62. Karring H, Runager K, Thogersen IB, Klintworth GK, Hojrup P, Enghild JJ. Composition and proteolytic processing of corneal deposits associated with mutations in the TGFBI gene. Exp Eye Res. 2012; 96: 163-170. doi: 10.1016/j.exer.2011.11.014 PMID: 22155582
63. Jurkunas UV, Bitar M, Rawe I. Colocalization of increased transforming growth factor-beta-induced protein (TGFBIp) and Clusterin in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2009; 50: 1129-1136. doi: 10.1167/iovs.08-2525 PMID: 19011008
64. Korvatska E, Henry H, Mashima Y, Yamada M, Bachmann C, Munier FL, et al. Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein. J Biol Chem. 2000; 275: 11465-11469. PMID: 10753964
65. Murphy-Ullrich JE, Mosher DF. Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation. J Cell Biol. 1987; 105: 1603-1611. PMID: 2444599
66. Wienke D, MacFadyen JR, Isacke CM. Identification and characterization of the endocytic transmembrane glycoprotein Endo180 as a novel collagen receptor. Mol Biol Cell. 2003; 14: 3592-3604. PMID: 12972549
67. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 1998; 93: 411-422. PMID: 9590175
68. Lim JS, Choy HE, Park SC, Han JM, Jang IS, Cho KA. Caveolae-mediated entry of Salmonella typhimurium into senescent nonphagocytotic host cells. Aging Cell. 2010; 9: 243-251. doi: 10.1111/j.1474- 9726.2010.00554.x PMID: 20096033
69. Wheaton K, Sampsel K, Boisvert FM, Davy A, Robbins S, Riabowol K. Loss of functional caveolae during senescence of human fibroblasts. J Cell Physiol. 2001; 187: 226-235. PMID: 11268002
70. Park WY, Park JS, Cho KA, Kim DI, Ko YG, Seo JS, et al. Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. J Biol Chem. 2000; 275: 20847-20852. PMID: 10781609
71. Kim JE, Kim SJ, Lee BH, Park RW, Kim KS, Kim IS. Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3. J Biol Chem. 2000; 275: 30907-30915. PMID: 10906123
72. Raub TJ, Kuentzel SL. Kinetic and morphological evidence for endocytosis of mammalian cell integrin receptors by using an anti-fibronectin receptor beta subunit monoclonal antibody. Exp Cell Res. 1989; 184: 407-426. PMID: 2530101
73. Van Nhieu GT, Krukonis ES, Reszka AA, Horwitz AF, Isberg RR. Mutations in the cytoplasmic domain of the integrin beta1 chain indicate a role for endocytosis factors in bacterial internalization. J Biol Chem. 1996; 271: 7665-7672. PMID: 8631804
74. Shi F, Sottile J. Caveolin-1-dependent beta1 integrin endocytosis is a critical regulator of fibronectin turnover. J Cell Sci. 2008; 121: 2360-2371. doi: 10.1242/jcs.014977 PMID: 18577581
75. Johnson MS, Lu N, Denessiouk K, Heino J, Gullberg D. Integrins during evolution: evolutionary trees and model organisms. Biochim Biophys Acta. 2009; 1788: 779-789. doi: 10.1016/j.bbamem.2008.12. 013 PMID: 19161977
76. Pellinen T, Tuomi S, Arjonen A, Wolf M, Edgren H, Meyer H, et al. Integrin trafficking regulated by Rab21 is necessary for cytokinesis. Dev Cell. 2008; 15: 371-385. doi: 10.1016/j.devcel.2008.08.001 PMID: 18804435
77. Galvez BG, Matias-Roman S, Yanez-Mo M, Vicente-Manzanares M, Sanchez-Madrid F, Arroyo AG. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell. 2004; 15: 678-687. PMID: 14657245
78. Nishimura T, Kaibuchi K. Numb controls integrin endocytosis for directional cell migration with aPKC and PAR-3. Dev Cell. 2007; 13: 15-28. PMID: 17609107
79. Caswell PT, Vadrevu S, Norman JC. Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol. 2009; 10: 843-853. doi: 10.1038/nrm2799 PMID: 19904298
80. Fabbri M, Di Meglio S, Gagliani MC, Consonni E, Molteni R, Bender JR, et al. Dynamic partitioning into lipid rafts controls the endo-exocytic cycle of the alphaL/beta2 integrin, LFA-1, during leukocyte chemotaxis. Mol Biol Cell. 2005; 16: 5793-5803. PMID: 16207819
81. Hu DD, Lin EC, Kovach NL, Hoyer JR, Smith JW. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem. 1995; 270: 26232-26238. PMID: 7592829
82. Simon KO, Nutt EM, Abraham DG, Rodan GA, Duong LT. The alphavbeta3 integrin regulates alpha5- beta1-mediated cell migration toward fibronectin. J Biol Chem. 1997; 272: 29380-29389. PMID: 9361020
83. Sigismund S, Woelk T, Puri C, Maspero E, Tacchetti C, Transidico P, et al. Clathrin-independent endocytosis of ubiquitinated cargos. Proc Natl Acad Sci U S A. 2005; 102: 2760-2765. PMID: 15701692
84. Yu A, Malek TR. The proteasome regulates receptor-mediated endocytosis of interleukin-2. J Biol Chem. 2001; 276: 381-385. PMID: 11032838
85. Chondrogianni N, Gonos ES. Proteasome dysfunction in mammalian aging: steps and factors involved. Exp Gerontol. 2005; 40: 931-938. PMID: 16246514
86. Friguet B, Bulteau AL, Chondrogianni N, Conconi M, Petropoulos I. Protein degradation by the proteasome and its implications in aging. Ann N Y Acad Sci. 2000; 908: 143-154. PMID: 10911955
87. Keller JN, Hanni KB, Markesbery WR. Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech Ageing Dev. 2000; 113: 61-70. PMID: 10708250
88. Carrard G, Bulteau AL, Petropoulos I, Friguet B. Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol. 2002; 34: 1461-1474. PMID: 12200039
89. Shang F, Taylor A. Function of the ubiquitin proteolytic pathway in the eye. Exp Eye Res. 2004; 78: 1-14. PMID: 14667823